Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study

CONCLUSIONS: Using an unsupervised network-based fusion method on plasma lipidomics and proteomics data from two independent cohorts, we were able to identify two subgroups of T2D patients differing in terms of disease severity. The molecular signatures identified within these subgroups provide insights into disease mechanisms and possibly new prognostic markers for T2D.PMID:38510703 | PMC:PMC10951062 | DOI:10.3389/fendo.2024.1350796
Source: Genomics Proteomics ... - Category: Genetics & Stem Cells Authors: Source Type: research